{
  "compound": "CBD",
  "condition": "ARTHRITIS",
  "effect_size": "Large sustained effect (Cohen's d = 0.84 at 18 months)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:ARTHRITIS_OBSERVATIONAL_003",
  "participants": "412 RA patients using CBD long-term",
  "year": 2021,
  "notes": "Long-Term Cannabidiol Use in Rheumatoid Arthritis: 18-Month Safety and Efficacy Study",
  "confidence": "medium",
  "abstract": "67% maintained low disease activity (DAS28-CRP <3.2) at 18 months; minimal tolerance development (dose increase <20% over 18 months)"
}